Retinitis

(redirected from Cytomegalovirus retinitis)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Cytomegalovirus retinitis: Cytomegalovirus infection, Mycobacterium avium complex

retinitis

[‚ret·ən′īd·əs]
(medicine)
Inflammation of the retina.

Retinitis

 

inflammation of the retina, generally in both eyes. It results from purulent infection of the retinal vessels caused by sepsis, a purulent focus, tuberculosis or other infectious diseases, or poisoning. Retinitis is usually accompanied by inflammation of the choroid (chorioretinitis). A characteristic development is the appearance of scotomata, or areas of depressed vision within the visual field that correspond to the inflammatory focus in the fundus of the eye. If treatment is inadequate, the depression of vision becomes permanent. Treatment depends on the causative disease.

References in periodicals archive ?
Burden of HIV-related cytomegalovirus retinitis in resource limited settings: A systematic review.
Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.
Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy.
Retinal detachment in AIDS-related cytomegalovirus retinitis.
Foscarnet therapy of cytomegalovirus retinitis in AIDS.
Of 80 patients with newly diagnosed cytomegalovirus retinitis who were randomized to receive induction therapy with oral valganciclovir--a prodrug that is rapidly hydrolyzed to ganciclovir--l0% experienced progression of the retinitis during the first 4 weeks of therapy, and 71.
The antiviral medication cidofovir was recently approved for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Cidofovir (Vistide) is already marketed by Gilead Sciences in an intravenous preparation for the treatment of cytomegalovirus retinitis.
Approved June 27, 1996 for the treatment of AIDS-related cytomegalovirus retinitis.
Swann suffers from cytomegalovirus retinitis, a disease common among AIDS patients that can lead to blindness within a week.